The vagina as a route for systemic drug delivery

被引:300
作者
Hussain, A [1 ]
Ahsan, F [1 ]
机构
[1] Texas Tech Univ, Ctr Hlth Sci, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA
关键词
vagina; drug delivery; contraception; vaginal enzymes; bioadhesion; peptides and proteins;
D O I
10.1016/j.jconrel.2004.11.034
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Exhaustive efforts have been made toward the administration of drugs, via alternative routes, that are poorly absorbed after the oral administration. The vagina as a route of drug delivery has been known since ancient times. In recent years, the vaginal route has been rediscovered as a potential route for systemic delivery of peptides and other therapeutically important macromolecules. However, successful delivery of drugs through the vagina remains a challenge, primarily due to the poor absorption across the vaginal epithelium. The rate and extent of drug absorption after intravaginal administration may vary depending on formulation factors, vaginal physiology, age of the patient and menstrual cycle. Suppositories, creams, gels, tablets and vaginal rings are commonly used vaginal drug delivery systems. The purpose of this communication is to provide the reader with a summary of advances made in the field of vaginal drug delivery. This report, therefore, summarizes various vaginal drug delivery systems with an introduction to vaginal physiology and factors affecting drug absorption from the vaginal route. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:301 / 313
页数:13
相关论文
共 86 条
[51]  
Majoko F, 2002, Cent Afr J Med, V48, P123
[52]   Swelling-controlled release system for the vaginal delivery of miconazole [J].
Mandal, TK .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (03) :337-343
[53]  
Masters WH, 1966, HUMAN SEXUAL RESPONS
[54]  
MORIMOTO K, 1982, INT J PHARM, V12, P107
[55]   The combined contraceptive vaginal ring, NuvaRing®:: an international study of user acceptability [J].
Novák, A ;
de la Loge, C ;
Abetz, L ;
van der Meulen, EA .
CONTRACEPTION, 2003, 67 (03) :187-194
[56]  
OGRA PL, 1994, HDB MUCOSAL IMMUNOLO, P1
[57]   VAGINAL ABSORPTION OF A POTENT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG (LEUPROLIDE) IN RATS-I - ABSORPTION BY VARIOUS ROUTES AND ABSORPTION ENHANCEMENT [J].
OKADA, H ;
YAMAZAKI, I ;
OGAWA, Y ;
HIRAI, S ;
YASHIKI, T ;
MIMA, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (12) :1367-1371
[58]   Factors influencing nonoxynol-9 permeation and bioactivity in cervical mucus [J].
Owen, DH ;
Dunmire, EN ;
Planys, AM ;
Katz, DF .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (01) :23-34
[59]  
PAAVONEN J, 1983, SCAND J INFECT DIS, P31
[60]  
Platzner W., 1978, HUMAN REPROD MED HUM, P39